The Cellular Diagnostics market is a subset of the larger Genomics market, which focuses on the study of cells and their components. Cellular Diagnostics is the application of genomics to the diagnosis and treatment of diseases. It involves the use of genetic tests to identify and characterize genetic mutations, as well as to detect and monitor the progression of diseases. This type of testing is used to diagnose a wide range of conditions, including cancer, cardiovascular disease, and neurological disorders. Cellular Diagnostics is a rapidly growing field, with new technologies and applications being developed to improve the accuracy and speed of diagnosis. This has enabled the development of personalized treatments, which are tailored to the individual patient's genetic makeup. Companies in the Cellular Diagnostics market include Illumina, Thermo Fisher Scientific, Qiagen, Agilent Technologies, and Roche. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
